• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重排肺癌中的非细菌性血栓性心内膜炎:两例报告。

Non-bacterial thrombotic endocarditis in -rearranged lung cancer: a report of two cases.

作者信息

Recuero-Borau Jordi, Masfarré Laura, Navarro Nil, Rocha Pedro, Taus Álvaro, Arriola Edurne

机构信息

Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.

出版信息

Transl Lung Cancer Res. 2024 Jan 31;13(1):179-185. doi: 10.21037/tlcr-23-412. Epub 2024 Jan 22.

DOI:10.21037/tlcr-23-412
PMID:38404995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10891407/
Abstract

BACKGROUND

Lung cancer is one of the tumor types with highest incidence of thromboembolic events (TE), especially adenocarcinoma subtype. rearrangements confer higher risk of TE. Non-bacterial thrombotic endocarditis (NBTE) is a rare event, frequently diagnosed on autopsy. Clinical suspicion is key to reach the diagnosis and start early treatment of the underlying cause and anticoagulation in order to improve patients' outcomes.

CASE DESCRIPTION

Here we present two cases of NBTE in patients with -rearranged lung cancer with different clinical debuts. A 42-year-old woman presented initial tetraplegia and impaired level of consciousness, and the other patient, a 54-year-old man, was diagnosed of stroke with sensitive loss of left body. Both were diagnosed of NBTE, confirmed by the finding of cardiac vegetation on echocardiogram and no microorganisms found on blood cultures. Both responded well to targeted therapy with lorlatinib and crizotinib and anticoagulation with heparin.

CONCLUSIONS

NBTE is an infrequent disease which can cause severe neurological symptoms that impair quality of life, performance status and survival. Early clinical suspicion in patients with higher risk of TEs such as patients with rearrangements of gene is of essence. Adequate management of underlying disease and anticoagulation may impact in the recovery of symptoms.

摘要

背景

肺癌是血栓栓塞事件(TE)发生率最高的肿瘤类型之一,尤其是腺癌亚型。基因重排会增加TE的风险。非细菌性血栓性心内膜炎(NBTE)是一种罕见事件,常在尸检时被诊断出来。临床怀疑是做出诊断以及开始对潜在病因进行早期治疗和抗凝以改善患者预后的关键。

病例描述

在此,我们呈现两例基因重排型肺癌患者发生NBTE的病例,其临床表现各异。一名42岁女性最初出现四肢瘫痪和意识水平受损,另一名患者是一名54岁男性,被诊断为中风并伴有左侧身体感觉丧失。两人均被诊断为NBTE,经超声心动图发现心脏赘生物且血培养未发现微生物得以证实。两人对洛拉替尼和克唑替尼靶向治疗以及肝素抗凝治疗反应良好。

结论

NBTE是一种罕见疾病,可导致严重的神经症状,损害生活质量、身体状况和生存率。对于TE风险较高的患者,如基因重排患者,早期临床怀疑至关重要。对基础疾病进行充分管理和抗凝可能会影响症状的恢复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cbd/10891407/2898e5dfb858/tlcr-13-01-179-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cbd/10891407/1ac35de0fa2b/tlcr-13-01-179-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cbd/10891407/82f91d45142e/tlcr-13-01-179-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cbd/10891407/aa31361e7858/tlcr-13-01-179-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cbd/10891407/2898e5dfb858/tlcr-13-01-179-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cbd/10891407/1ac35de0fa2b/tlcr-13-01-179-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cbd/10891407/82f91d45142e/tlcr-13-01-179-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cbd/10891407/aa31361e7858/tlcr-13-01-179-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cbd/10891407/2898e5dfb858/tlcr-13-01-179-f4.jpg

相似文献

1
Non-bacterial thrombotic endocarditis in -rearranged lung cancer: a report of two cases.重排肺癌中的非细菌性血栓性心内膜炎:两例报告。
Transl Lung Cancer Res. 2024 Jan 31;13(1):179-185. doi: 10.21037/tlcr-23-412. Epub 2024 Jan 22.
2
Recurrent embolic strokes due to antiphospholipid syndrome and non-bacterial thrombotic endocarditis in a patient with basal cell carcinoma.基底细胞癌患者因抗磷脂综合征和非细菌性血栓性心内膜炎导致复发性脑栓塞。
J Cardiothorac Surg. 2023 May 11;18(1):177. doi: 10.1186/s13019-023-02266-6.
3
Embolic Showering from Non-Bacterial Thrombotic Endocarditis and Adenocarcinoma of the Lung.非细菌性血栓性心内膜炎及肺腺癌引发的栓子播散
Eur J Case Rep Intern Med. 2020 Jul 20;7(10):001798. doi: 10.12890/2020_001798. eCollection 2020.
4
Management of nonbacterial thrombotic endocarditis (NBTE) in advanced non-small cell lung cancer (NSCLC) patients with driver mutation: two case reports.驱动基因突变的晚期非小细胞肺癌(NSCLC)患者非细菌性血栓性心内膜炎(NBTE)的管理:两例报告
Ann Palliat Med. 2021 Mar;10(3):3475-3482. doi: 10.21037/apm-21-251. Epub 2021 Mar 10.
5
Unveiling Lung Adenocarcinoma: Non-bacterial Thrombotic Endocarditis as the Debut Sign.揭示肺腺癌:非细菌性血栓性心内膜炎为首发症状
Cureus. 2023 Sep 14;15(9):e45271. doi: 10.7759/cureus.45271. eCollection 2023 Sep.
6
Cardiac involvement in Behçet disease presenting as non-bacterial thrombotic endocarditis: A case report.以非细菌性血栓性心内膜炎为表现的白塞病心脏受累:一例报告。
J Cardiol Cases. 2021 Apr 7;24(4):157-160. doi: 10.1016/j.jccase.2021.03.003. eCollection 2021 Oct.
7
Stroke due to non-bacterial thrombotic endocarditis as initial presentation of breast invasive ductal carcinoma.非细菌性血栓性心内膜炎所致中风作为乳腺浸润性导管癌的首发表现
Acta Clin Belg. 2017 Aug;72(4):268-273. doi: 10.1080/17843286.2016.1219012. Epub 2016 Aug 12.
8
A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumab.ROS1 G2032 K 错义突变介导 ROS1 重排肺腺癌患者对 lorlatinib 的耐药,但对纳武利尤单抗联合白蛋白紫杉醇有效。
Lung Cancer. 2020 May;143:55-59. doi: 10.1016/j.lungcan.2020.03.019. Epub 2020 Mar 19.
9
Association of anticoagulant use with clinical outcomes from crizotinib in ALK- and ROS1-rearranged advanced non-small cell lung cancers: A retrospective analysis of PROFILE 1001.克唑替尼治疗ALK 和 ROS1 重排的晚期非小细胞肺癌的临床结局与抗凝药物使用的相关性:PROFILE 1001 的回顾性分析。
Cancer Med. 2022 Dec;11(23):4422-4429. doi: 10.1002/cam4.4789. Epub 2022 May 5.
10
Cancer-associated non-bacterial thrombotic endocarditis.癌相关非细菌性血栓性心内膜炎。
Thromb Res. 2022 May;213 Suppl 1:S127-S132. doi: 10.1016/j.thromres.2021.11.024. Epub 2022 May 26.

引用本文的文献

1
Clinical insights into nonbacterial thrombotic endocarditis in cancer patients: A case-based systematic review.癌症患者非细菌性血栓性心内膜炎的临床见解:一项基于病例的系统评价。
ARYA Atheroscler. 2025;21(4):55-78. doi: 10.48305/arya.2025.45107.3045.
2
Acute Myocardial and Hemorrhagic Cerebral Infarction Secondary to Non-bacterial Thrombotic Endocarditis in a Patient with Advanced Uterine and Ovarian Cancer.晚期子宫和卵巢癌患者继发非细菌性血栓性心内膜炎的急性心肌梗死和出血性脑梗死
Intern Med. 2025 Jul 1;64(13):2002-2006. doi: 10.2169/internalmedicine.4571-24. Epub 2024 Dec 26.

本文引用的文献

1
The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.2023 年杜克-国际心血管感染性疾病学会感染性心内膜炎标准:修改后的杜克标准更新。
Clin Infect Dis. 2023 Aug 22;77(4):518-526. doi: 10.1093/cid/ciad271.
2
Lung Cancer as a Leading Cause among Paraneoplastic Non-Bacterial Thrombotic Endocarditis: A Meta-Analysis of Individual Patients' Data.肺癌是副肿瘤性非细菌性血栓性心内膜炎的主要病因之一:个体患者数据的荟萃分析
Cancers (Basel). 2023 Mar 20;15(6):1848. doi: 10.3390/cancers15061848.
3
Contemporary demographics, diagnostics and outcomes in non-bacterial thrombotic endocarditis.
非细菌性血栓性心内膜炎的当代人口统计学、诊断方法及治疗结果
Heart. 2022 May 9. doi: 10.1136/heartjnl-2022-320970.
4
Association of anticoagulant use with clinical outcomes from crizotinib in ALK- and ROS1-rearranged advanced non-small cell lung cancers: A retrospective analysis of PROFILE 1001.克唑替尼治疗ALK 和 ROS1 重排的晚期非小细胞肺癌的临床结局与抗凝药物使用的相关性:PROFILE 1001 的回顾性分析。
Cancer Med. 2022 Dec;11(23):4422-4429. doi: 10.1002/cam4.4789. Epub 2022 May 5.
5
High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations.不同基因组改变的非小细胞肺癌患者血栓形成事件存在高度差异。
Transl Lung Cancer Res. 2021 Mar;10(3):1512-1524. doi: 10.21037/tlcr-20-1290.
6
Meningeal "Lazarus Response" to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib.一名对恩曲替尼耐药的ROS1阳性非小细胞肺癌患者脑膜对劳拉替尼的“拉撒路反应”
Cancer Manag Res. 2021 Mar 26;13:2805-2810. doi: 10.2147/CMAR.S292730. eCollection 2021.
7
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.美国血液学会 2021 年静脉血栓栓塞症管理指南:癌症患者的预防和治疗。
Blood Adv. 2021 Feb 23;5(4):927-974. doi: 10.1182/bloodadvances.2020003442.
8
Embolic Showering from Non-Bacterial Thrombotic Endocarditis and Adenocarcinoma of the Lung.非细菌性血栓性心内膜炎及肺腺癌引发的栓子播散
Eur J Case Rep Intern Med. 2020 Jul 20;7(10):001798. doi: 10.12890/2020_001798. eCollection 2020.
9
ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events.ROS1 基因重排与诊断前血栓栓塞事件风险升高相关。
J Thorac Oncol. 2019 Apr;14(4):596-605. doi: 10.1016/j.jtho.2018.12.001. Epub 2018 Dec 10.
10
Nonbacterial Thrombotic Endocarditis: Pathogenesis, Diagnosis, and Management.非细菌性血栓性心内膜炎:发病机制、诊断与管理
Cardiol Rev. 2016 Sep-Oct;24(5):244-7. doi: 10.1097/CRD.0000000000000106.